The Latest Breaking News from Food and Drug Administration

The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.

The United States Food and Drug Administration had audited the facility in September 2023.

The U.S. Food and Drug Administration has recalled the products linked to the outbreak and warned consumers not to eat, sell or serve them.

The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorised by the UK’s medicines regulation authority for use in weight loss and weight management. The decision was made on the same day the US Food and Drug Administration (FDA) approved a version of…

Yet another year of low ratings for the apparatus of the D.C. leviathan.

Drugs and medical devices rarely come from the nonprofit world

Here’s a guide to what consumers need to know about the first daily oral contraceptive that will be available for sale without a prescription.

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

A recent Food and Drug Administration rule requires healthcare providers to notify people if they have dense breasts. Studies have shown that dense breast tissue can make it more difficult to detect breast cancer early.